FDA shakes down Hospira facility in a 3-week inspection

March 14, 2013 by Sony Salzman

The FDA completes a 3-week inspection of Hospira's Rocky Mount, N.C., facility, which has been under the watchdog agency's eye since an April 2010 warning letter.

Correction - this article mistakenly suggested that the manufacturing facility in question produces infusion pumps.

Hospira logo

Medical device company Hospira (NYSE:HSP) disclosed an FDA inspection of its Rocky Mount, N.C., facility, saying 5 agency inspectors reviewed the facility for 3 weeks and issued a Form 483 warning flagging 20 problems at the plant.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Comments

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp